हिंदी में पढ़ें

Glenmark Life Sciences

8 large- and mid-cap pharma stocks that have more than doubled in a year

8 large- and mid-cap pharma stocks that have more than doubled in a year

Fri, Apr 26, 2024

Wockhardt, Lupin, Jubilant Pharma, Concord Biotech and Shilpa Medicare have been some of the top pharma stocks in the 1-year period.

Glenmark Life Sciences Q3 results: Net profit rises 13% at Rs 119 crore

Glenmark Life Sciences Q3 results: Net profit rises 13% at Rs 119 crore

Tue, Jan 23, 2024

"Our Q3 FY24 numbers reflect our commitment to quality growth, with revenue from operations rising by 5.9 per cent. This was fuelled by the robust performance of the US, LATAM (Latin American), RoW (Rest of the World) and India markets," Glenmark Life Sciences MD & CEO Yasir Rawjee said.

Glenmark Life Sciences Q2 PAT rises 11% to Rs 119 crore

Glenmark Life Sciences Q2 PAT rises 11% to Rs 119 crore

Fri, Oct 20, 2023

Glenmark Life Sciences Q2 Results: Glenmark Life Sciences said its profit after tax rose 11 per cent year-on-year to Rs 119 crore for the second quarter ended September 30, 2023.

TRENDING NOW

1,150% dividend: This pharma stock to trade ex-date on Tuesday

1,150% dividend: This pharma stock to trade ex-date on Tuesday

Mon, Oct 16, 2023

Glenmark Life Sciences dividend record date 2023: Mumbai-based active pharmaceutical ingredients (API) manufacturer Glenmark Life Sciences earlier announced a dividend of Rs 22.5 per equity share, its first interim dividend for the financial year.

Glenmark Life Sciences announces interim dividend for FY24

Glenmark Life Sciences announces interim dividend for FY24

Mon, Oct 09, 2023

Glenmark Life Sciences in its board meeting today (October 9) announced an interim dividend of Rs 22.5 per share.

Glenmark Life Sciences board to consider Q2 results, dividend on this date

Glenmark Life Sciences board to consider Q2 results, dividend on this date

Thu, Oct 05, 2023

Glenmark Life Sciences board meeting: Glenmark Life Sciences’ board is scheduled to meet next week to consider and approve its quarterly financial results and what could be the company’s first interim dividend for the current financial year.

Glenmark Pharma share jumps over 6% as S&P Global upgrades rating from 'stable' to 'positive'

Glenmark Pharma share jumps over 6% as S&P Global upgrades rating from 'stable' to 'positive'

Fri, Sep 29, 2023

Last seen, shares of Glenmark Pharma traded 5.17 per cent higher at Rs 818.20 apiece. The market capitalisation of the company stood at around Rs 23,127 crore. The stock continued its rally for the third consecutive session.

Glenmark Life hits 52-week high as reports say Sekhmet and Nirma Group in race to acquire company

Glenmark Life hits 52-week high as reports say Sekhmet and Nirma Group in race to acquire company

Mon, Jun 12, 2023

Glenmark Life Sciences share price: The scrip zoomed after reports said that Mumbai-based pharmaceutical company Sekhmet Pharmaventures and Ahmedabad-based Nirma Group are in race to acquire Glenmark Life Sciences.

1,050% DIVIDEND: Mumbai-based pharma API maker woos Street with dividend payout — check out record date

1,050% DIVIDEND: Mumbai-based pharma API maker woos Street with dividend payout — check out record date

Fri, Mar 17, 2023

Glenmark Life Sciences dividend news 2023: The stock of Glenmark Life Sciences — a Mumbai-based manufacturer of active pharmaceutical ingredients (APIs) — jumped almost five per cent on Friday, after the company's board declared a dividend of Rs 21 per equity share of face value Rs 2.

Tata Elxsi, Glenmark Life Sciences, ICICI Securities— How stocks fared post march quarter results?

Tata Elxsi, Glenmark Life Sciences, ICICI Securities— How stocks fared post march quarter results?

Thu, Apr 21, 2022

Tata Elxsi, Glenmark Life Sciences, ICICI Securities came up with their March quarter results on Wednesday.

Glenmark Life Sciences will start working on the Greenfield project from November: Dr Yasir Rawjee, MD&CEO

Glenmark Life Sciences will start working on the Greenfield project from November: Dr Yasir Rawjee, MD&CEO

Mon, Aug 30, 2021

Dr Yasir Rawjee, Managing Director and Chief Executive Officer, Glenmark Life Sciences, talks about listing, Q1FY22 numbers, API business, CDMO business, debt situation and CapEx plan among others during a candid chat with Swati Khandelwal, Zee Business. Edited Excerpts:

Glenmark Life Sciences share price on Monday - stock falls 1.5% on BSE - second straight correction since listing on Friday

Glenmark Life Sciences share price on Monday - stock falls 1.5% on BSE - second straight correction since listing on Friday

Mon, Aug 09, 2021

Glenmark Life Sciences Limited, which made its market debut on 6 August fell on Monday - its second trading day on the go. The stock fell by almost 5% on Monday on the intraday basis taking it to a low of Rs 713.85 before settling at Rs 736.90 at the end of today's trading session.

Glenmark Life Sciences make lukewarm debut on exchanges: Share listed as per Anil Singhvi’s expectations- Check details

Glenmark Life Sciences make lukewarm debut on exchanges: Share listed as per Anil Singhvi’s expectations- Check details

Fri, Aug 06, 2021

Glenmark Life Sciences is an API subsidiary of Glenmark Pharma, as 40 per cent of its business comes from the parent company.

Glenmark Life Sciences IPO: TOP 12 things to know

Glenmark Life Sciences IPO: TOP 12 things to know

Fri, Jul 23, 2021

The company will be coming up with initial public offerings to raise funds through fresh issue of equity shares aggregating up to Rs 1,060 crore.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x